Delivery Order SPE2DB22D1202-SPE2DB24FVBK4
Award Date
5/24/24
Potential Completion Date
5/28/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,845.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,673,566 milliliters of the pharmaceutical product glycopyrrolate 1 mg/5 ml vial. The contract is a Firm Fixed Price Delivery Order with a completion date of May 22, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
This federal contract award, valued at $1,030.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, which is not set-aside, is for the delivery of GLYCOPYRROLATE INJECT, a pharmaceutical product, with a completion date of August 27, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts to supply a wide range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the U.S. Department of Defense (DoD) and other government agencies with a specific medication, glycopyrrolate 0.2 mg/ml vial 20ml. The contract, valued at $2,704.75, is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $4,591.37 firm fixed-price delivery order is for the supply of the medication glycopyrrolate, with a 2-milliliter vial as the unit of measure. The contract has a period of performance through July 22, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Glycopyrrolate 0.2 mg/mL vials. The $7,201.28 award has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment programs...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical in the amount of $4,301.94. The contract is for the supply of the pharmaceutical product GLYCOPYRROLATE INJECT to support military treatment programs and facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,025.07 delivery order is for the supply of 4 mg/20 ml vials of the drug glycopyrrolate, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of September 11, 2024. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical products to support...
This federal contract award, valued at $1,241.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glycopyrrolate 0.2 mg/ml vials (5 ml) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the supply of GLYCOPYRROLATE INJECT medication. The contract, valued at $2,381.99, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 25, 2024. This award is not associated with any set-aside program. Amerisourcebergen, a major pharmaceutical...